Open Market Insiders Trades
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- P - Open market or private purchase of non-derivative or derivative security
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
NSTG
|
R Bradley Gray
President and CEO |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 22.38% |
$1,818,250
$72.73 p/Share
|
Jan 20
2021 |
RMNI
|
Daniel B. Winslow
EVP, CLO & Corp. Sec. |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 34.06% |
$70,800
$7.08 p/Share
|
Jan 20
2021 |
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 12,800 Reduced 0.78% |
$320,128
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
William Thomas Grant Iii
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Indirect | 17,231 Reduced 0.91% |
$430,947
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Direct | 12,800 Reduced 0.43% |
$320,128
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
W Thomas Grant Ii
Director |
SELL
Open market or private sale
|
Indirect | 12,800 Reduced 0.8% |
$320,128
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
Robert Clay Grant
PRESIDENT |
SELL
Open market or private sale
|
Direct | 12,838 Reduced 1.0% |
$321,078
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
Robert Clay Grant
PRESIDENT |
SELL
Open market or private sale
|
Indirect | 17,185 Reduced 0.91% |
$429,797
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
Paul L Gregory
Officer |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 14.85% |
$999,600
$24.99 p/Share
|
Jan 20
2021 |
SLQT
|
Raffaele Sadun
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 12,791 Reduced 1.21% |
$319,903
$25.01 p/Share
|
Jan 20
2021 |
SLQT
|
Timothy Robert Danker
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 12,900 Reduced 0.74% |
$322,629
$25.01 p/Share
|
Jan 20
2021 |
KOD
|
Jason Ehrlich
Officer |
SELL
Open market or private sale
|
Direct | 26,950 Reduced 34.87% |
$4,413,062
$163.75 p/Share
|
Jan 20
2021 |
MRSN
|
Timothy B Lowinger
SVP, Chief Sci.&Tech. Officer |
SELL
Open market or private sale
|
Direct | 8,203 Reduced 20.69% |
$176,693
$21.54 p/Share
|
Jan 20
2021 |
LEGH
|
Kenneth E Shipley
Executive Vice President |
SELL
Open market or private sale
|
Direct | 8,487 Reduced 0.27% |
$131,209
$15.46 p/Share
|
Jan 20
2021 |
APEI
|
Timothy J Landon
Director |
SELL
Open market or private sale
|
Direct | 350 Reduced 2.07% |
$10,910
$31.17 p/Share
|
Jan 20
2021 |
FULC
|
Robert J Gould |
SELL
Open market or private sale
|
Direct | 10,000 Reduced 1.87% |
$120,800
$12.08 p/Share
|
Jan 20
2021 |
JNCE
|
Elizabeth Trehu
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 6,500 Reduced 8.35% |
$78,065
$12.01 p/Share
|
Jan 20
2021 |
JNCE
|
John Duncan Higgons
Director |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 12.49% |
$18,000
$12.0 p/Share
|
Jan 20
2021 |
JNCE
|
Kimberlee C Drapkin
President, CFO and Treasurer |
SELL
Open market or private sale
|
Direct | 26,201 Reduced 37.76% |
$288,997
$11.03 p/Share
|
Jan 20
2021 |
PASG
|
Jill M. Quigley
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 1,300 Reduced 0.44% |
$39,013
$30.01 p/Share
|
Jan 20
2021 |
MMNFF
|
Wicklow Capital Inc.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 309,120 Reduced 1.54% |
$71,098
$0.23 p/Share
|
Jan 20
2021 |
PCF
|
Andrew Dakos
President |
SELL
Open market or private sale
|
Direct | 1,900 Reduced 7.92% |
$16,568
$8.72 p/Share
|
Jan 20
2021 |
SIEN
|
Oliver Christian Bennett
GC & Chief Compliance Officer |
SELL
Open market or private sale
|
Direct | 4,399 Reduced 5.91% |
$19,752
$4.49 p/Share
|
Jan 20
2021 |
IVC
|
Anthony La Placa
Sr. VP, GC, CAO & Secretary |
SELL
Open market or private sale
|
Direct | 1,500 Reduced 1.98% |
$15,675
$10.45 p/Share
|
Jan 20
2021 |
AAOI
|
David C Kuo
Officer |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.27% |
$11,000
$11.0 p/Share
|
Jan 20
2021 |
GRF
|
Luke E Sims
President & CEO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.59% |
$40,100
$8.02 p/Share
|
Jan 20
2021 |
AYLA
|
Roni Mamluk
President & CEO |
SELL
Open market or private sale
|
Direct | 19,466 Reduced 9.77% |
$292,574
$15.03 p/Share
|
Jan 20
2021 |
AYLA
|
Gary B. Gordon
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 26.04% |
$45,090
$15.03 p/Share
|
Jan 20
2021 |
CIFR
|
Glazer Capital, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 5,460 Reduced 0.24% |
$55,965
$10.25 p/Share
|
Jan 20
2021 |
EQIX
|
Charles J Meyers
Director |
SELL
Open market or private sale
|
Direct | 1,329 Reduced 10.61% |
$966,263
$727.06 p/Share
|
Jan 20
2021 |
SPT
|
Aaron Edward Frederick Rankin
Director |
SELL
Open market or private sale
|
Indirect | 37,000 Reduced 43.27% |
$2,402,410
$64.93 p/Share
|
Jan 20
2021 |
MCOA
|
Themistocles Psomiadis
Director |
SELL
Open market or private sale
|
Direct | 1,428,571 Reduced 12.5% |
$14,286
$0.01 p/Share
|
Jan 20
2021 |
SCYX
|
Perceptive Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 185,000 Reduced 7.71% |
$1,374,550
$7.43 p/Share
|
Jan 20
2021 |
ATUS
|
Michael Grau |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 19.62% |
$1,446,000
$36.15 p/Share
|
Jan 20
2021 |
CCEL
|
David Portnoy
Chairman, Co-CEO |
BUY
Open market or private purchase
|
Direct | 4,000 Added 0.78% |
$32,680
$8.17 p/Share
|
Jan 20
2021 |
BRN
|
Ned L Sherwood
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 18,906 Added 1.51% |
$34,976
$1.85 p/Share
|
Jan 20
2021 |
NYC
|
Edward M Weil Jr.
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 2.91% |
$1,470
$9.8 p/Share
|
Jan 20
2021 |
YORW
|
Steven R Rasmussen
Director |
BUY
Open market or private purchase
|
Direct | 12 Added 0.47% |
$555
$46.28 p/Share
|
Jan 20
2021 |
ADMQ
|
Marc Johnson
CEO |
BUY
Open market or private purchase
|
Direct | 4,200 Added 0.01% |
$378
$0.09 p/Share
|
Jan 20
2021 |
SREV
|
Edenbrook Capital, LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 6,256 Added 0.03% |
$9,384
$1.5 p/Share
|
Jan 20
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Indirect | 28 Added 0.37% |
$23,642
$844.34 p/Share
|
Jan 20
2021 |
TPL
|
Murray Stahl
Director |
BUY
Open market or private purchase
|
Direct | 5 Added 0.41% |
$4,222
$844.34 p/Share
|
Jan 20
2021 |
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 675 Added 0.24% |
$1,289
$1.91 p/Share
|
Jan 20
2021 |
ODC
|
Allan H Selig
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 2.17% |
$33,730
$33.73 p/Share
|
Jan 20
2021 |
OCX
|
Broadwood Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1,460,280 Added 8.28% |
$4,994,158
$3.42 p/Share
|
Jan 20
2021 |
OCX
|
Broadwood Partners, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 0 Added 0.0% |
-
|
Jan 20
2021 |
VTA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 3,725 Added 0.04% |
$40,900
$10.98 p/Share
|
Jan 20
2021 |
GIM
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 225,467 Added 1.0% |
$1,262,615
$5.6 p/Share
|
Jan 20
2021 |
PLPC
|
Andrew S Klaus
CFO |
BUY
Open market or private purchase
|
Direct | 12 Added 0.3% |
$839
$69.94 p/Share
|
Jan 20
2021 |
FRAF
|
Ronald L Cekovich
SVP |
BUY
Open market or private purchase
|
Direct | 4 Added 0.05% |
$111
$27.76 p/Share
|
Jan 20
2021 |